Yale University
New Haven, Connecticut, 06510, United States
NCT Number: NCT01675232
The purpose of this study is to investigate the efficacy of two different corticosteroid ointment application regimens for the treatment of eczema (atopic dermatitis).
Looking for future studies?
Notify Me2 week–18 year
All sexes
Interventional
Not applicable
New Haven, Connecticut, 06510, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Corticosteroid ointment applied to wet skin once a day and dry skin once a day.
Corticosteroid ointment applied to dry skin twice a day.
Time frame: 2 weeks
Time frame: 2 weeks after application of topical corticosteroids
Time frame: 3 months
Time frame: 3 months
Characterize and quantify adverse effects associated with each corticosteroid application regimen.
Yale University
Other
A Randomized, Investigator-Blinded Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05990725
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Augsburg, Germany
View Trial DetailsNCT07703215
Antioxidant Capacity, Atopic Dermatitis
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT05651711
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Litchfield Park, Arizona, United States
View Trial DetailsNCT06238817
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Little Rock, Arkansas, United States
View Trial Details